1. Home
  2. FCCO vs PLYX Comparison

FCCO vs PLYX Comparison

Compare FCCO & PLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Community Corporation

FCCO

First Community Corporation

HOLD

Current Price

$32.58

Market Cap

290.5M

Sector

Finance

ML Signal

HOLD

PLYX

Polaryx Therapeutics Inc. Common Stock

N/A

Current Price

$2.50

Market Cap

271.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FCCO
PLYX
Founded
1994
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
290.5M
271.8M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
FCCO
PLYX
Price
$32.58
$2.50
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
135.5K
144.0K
Earning Date
04-22-2026
05-22-2026
Dividend Yield
2.16%
N/A
EPS Growth
36.46
N/A
EPS
0.59
N/A
Revenue
$922,000.00
N/A
Revenue This Year
$30.67
N/A
Revenue Next Year
$5.87
N/A
P/E Ratio
$56.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.00
$2.01
52 Week High
$34.01
$9.18

Technical Indicators

Market Signals
Indicator
FCCO
PLYX
Relative Strength Index (RSI) 60.87 43.62
Support Level $29.26 $2.10
Resistance Level $33.03 $3.41
Average True Range (ATR) 0.97 0.22
MACD 0.09 0.09
Stochastic Oscillator 58.63 78.05

Price Performance

Historical Comparison
FCCO
PLYX

About FCCO First Community Corporation

First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are: Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.

About PLYX Polaryx Therapeutics Inc. Common Stock

Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal storage disorders segment consists of the Company's costs associated with the preclinical and clinical development of the Company's product candidates.

Share on Social Networks: